Alejandro Dorenbaum - 10 Dec 2021 Form 4 Insider Report for Reneo Pharmaceuticals, Inc. (OKUR)

Role: Chief Medical Officer
Signature: /s/ Vineet R. Jindal, Attorney-in-Fact
Issuer symbol: OKUR
Transactions as of: 10 Dec 2021
Net transactions value: $0
Form type: 4
Filing time: 14 Dec 2021, 15:30:05 UTC
Next filing: 13 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RPHM	Common Stock	Award	$0	+30,000	+134%	$0.000000	52,348	10 Dec 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RPHM	Stock option (right to buy)	Award	$0	+100,000		$0.000000	100,000	10 Dec 2021	Common Stock	100,000	$6.69	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a restricted stock unit award.
F2	The shares vest in a series of 48 successive equal monthly installments measured from December 10, 2021, subject to Reporting Persons's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date.